NEW YORK, NY / ACCESSWIRE / February 17, 2022 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.
FirstCash, Inc. (NASDAQ:FCFS)
This lawsuit is on behalf of all persons who purchased shares of FirstCash common stock between February 1, 2018 and November 12, 2021, both dates inclusive.
A class action has commenced on behalf of certain shareholders in FirstCash, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) FirstCash had made more than 3,600 loans to over 1,000 active-duty members of the military and their families at usurious interest rates above 36% – and often exceeding 200% – in violation of the Military Lending Act (“MLA”) and the Consent Order Cash America had entered into with the Consumer Financial Protection Bureau (the “Order”); (b) FirstCash had failed to implement the remedial measures imposed by the Order; (c) FirstCash’s financial results were, in substantial part, the product of the Company’s violations of the MLA and the Order; and (d) as a result of the foregoing, FirstCash was exposed to a material undisclosed risk of legal, reputational and financial harm if the Company’s violations of the MLA and the Order were ever publicly disclosed.
Shareholders may find more information at https://securitiesclasslaw.com/securities/firstcash-inc-loss-submission-form/?id=23838&from=1
First Solar, Inc. (NASDAQ:FSLR)
This lawsuit is on behalf of all persons or entities that purchased or otherwise acquired shares of First Solar common stock between February 22, 2019, and February 20, 2020, inclusive.
A class action has commenced on behalf of certain shareholders in First Solar, Inc. According to the filed complaint, defendants made repeated misrepresentations to investors regarding the development of First Solar’s newest “Series 6” solar module, the cost per unit it could achieve with that module, and the impact the changeover to this new product would have on the viability of its other business segments. As a result of defendants’ misrepresentations, First Solar common stock traded at artificially inflated prices during the class period.
Shareholders may find more information at https://securitiesclasslaw.com/securities/first-solar-inc-loss-submission-form/?id=23838&from=1
Biogen Inc. (NASDAQ:BIIB)
Investors Affected: June 7, 2021 – January 11, 2022
A class action has commenced on behalf of certain shareholders in Biogen Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: 1) there was a significant, undisclosed lobbying campaign between Biogen and the Food and Drug Administration (“FDA”) that was instrumental in the decision to file and approve Aduhelm, a drug being developed to treat Alzheimer’s disease; 2) the Phase III ENGAGE study demonstrated that Aduhelm failed to achieve a clinical benefit to Alzheimer’s patients; 3) ENGAGE was a failed study from which Biogen concluded not to seek FDA approval for Aduhelm in 2019; and 4) defendants misled investors as to the way in which approval was achieved, that the clinical data did not support a clinical benefit by taking Aduhelm and that side-effects were dangerous and serious.
Shareholders may find more information at https://securitiesclasslaw.com/securities/biogen-inc-loss-submission-form-2/?id=23838&from=1
The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (212) 537-9430
Fax: (833) 862-7770
SOURCE: The Gross Law Firm
View source version on accesswire.com:
https://www.accesswire.com/689412/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-FCFS-FSLR-and-BIIB
